KoBioLabs, Inc (KOSDAQ:348150)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,360.00
-110.00 (-2.01%)
At close: Apr 28, 2026

KoBioLabs Revenue

In the year 2025, KoBioLabs had annual revenue of 69.29B KRW with 1.36% growth. KoBioLabs had revenue of 15.12B in the quarter ending December 31, 2025, a decrease of -14.36%.

Revenue
69.29B
Revenue Growth
+1.36%
P/S Ratio
1.50
Revenue / Employee
n/a
Employees
n/a
Market Cap
104.09B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202569.29B932.96M1.36%
Dec 31, 202468.36B35.22B106.28%
Dec 31, 202333.14B21.53B185.54%
Dec 31, 202211.61B8.71B301.12%
Dec 31, 20212.89B-1.70B-36.98%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
CHA Vaccine Research Institute 158.62M
TegoScience 5.94B
SunBio,Inc. 2.17B
Cell Biotech 53.13B
Choong Ang Vaccine Laboratory 39.19B
CTCBIO 123.77B
NovMetaPharma 1.30B
Quratis 2.46B
Revenue Rankings